ResistancePlus MG and GC tests provide clinically relevant information to improve patient care for Mycoplasma genitalium (Mgen) and gonorrhoea infections.
SpeeDx and Cepheid are collaborating to evolve the practice of Resistance Guided Therapy even further. Join us and learn how new test technology is changing patient management practices.
Dr. Leanne Sammels
Leanne shares her experience of integrating resistance guided therapy into existing laboratory testing practices. Learn how she navigated additional clinician communications and workflow considerations to ensure clinically relevant turn around times.
Assoc Prof. Catriona Bradshaw
Catriona shares her extensive experiences of resistance guided therapy in the clinic, including her early access to ResistancePlus MG FleXible – near patient macrolide resistance testing for Mgen infections – and the expected impact of near-patient testing.
Date: 16th September 2019
Venue: Perth Convention & Exhibition Centre, Level 2, Northern Foyer and Meeting Room 2
Time: 4.30pm – 6.00pm
4.30pm drinks in Northern Foyer
4.45pm presentations in Meeting Room 2
5.15pm canapes in Northern Foyer